Answered

Westonci.ca is the Q&A platform that connects you with experts who provide accurate and detailed answers. Get immediate and reliable solutions to your questions from a community of experienced professionals on our platform. Experience the convenience of finding accurate answers to your questions from knowledgeable experts on our platform.

Which of the following direct factor Xa Inhibitors is used in combination with aspirin to reduce cardiovascular events in patients with chronic coronary artery disease (CAD) or peripheral artery disease?
a, Rivaroxaban
b. Apixaban
c. Edoxaban

Sagot :

We hope this was helpful. Please come back whenever you need more information or answers to your queries. Thank you for visiting. Our goal is to provide the most accurate answers for all your informational needs. Come back soon. Thank you for trusting Westonci.ca. Don't forget to revisit us for more accurate and insightful answers.